4.4 Article

The passive diffusion improvement of Vitamin B12 intestinal absorption by Gelucire that fit for commercialized production

期刊

SAUDI PHARMACEUTICAL JOURNAL
卷 31, 期 6, 页码 962-971

出版社

ELSEVIER
DOI: 10.1016/j.jsps.2023.04.024

关键词

Vitamin B 12 (VB 12 ); P-glycoprotein (P-gp); Gelucire 44; 14 (G44; 14); Intestinal absorption; Caco-2 cells; Everted gut sac

向作者/读者索取更多资源

Vitamin B12 is a vital micronutrient that cannot be synthesized by the human body and needs to be obtained from the diet. Its absorption in the gastrointestinal tract is mediated by intrinsic factor. The present study aims to increase VB12 intestinal absorption using cost-effective excipients and formulations.
Vitamin B12 (VB12) is a vital micronutrient to maintain the normal state of the hematopoietic system. It must be obtained from the diet since the human body cannot synthesize it. Moreover, the absorption of VB12 needs to be mediated by intrinsic factor on the gastrointestinal (GI) track. The abnormalities in the stomach or lack of such intrinsic factors may result in poor oral absorption of VB12. However, the very advanced formulation strategies were generally very costly and still in the development stage. Thus, the objectives of the present study were to increase the VB12 intestinal absorption by conventional excip-ients of Gelucire 44/14 (G44/14) or Labrasol, which could be potentially formulated as a cost effect bal-anced product.The in vitro Caco-2 cell model was applied for the absorption study. A novel VB12 solid dispersion was subsequently prepared and further characterized by Differential scanning calorimetry, Fourier transform infrared spectroscopy, and Scanning electron microscopy, respectively. The membrane permeability of the VB12 solid dispersion was finally evaluated using ex vivo rat everted gut sac method. The results sug-gested that G44/14 could significantly enhance the intestinal absorption of VB12 via P-glycoprotein inhi-bition in vitro (P < 0.01). The membrane permeability of VB12could be significantly (P < 0.01) improved by G44/14-VB12 solid dispersion at a proportion of carrier: drug ratio of 20:1.The liquidfied solid dispersion was finally directly filled in the hard gelatin capsules. In conclusion, the cheap and simplified process of VB12 complex prepared by G44/14 could potentially increase VB12 intestinal absorption, which may be liable to commercial manufacturing.(c) 2023 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据